About
Bio
Impact Factor:
3.767 (Source: 2015 Journal Citation Reports, Thomson Reuters 2016)
5-Year Impact Factor:
3.760 (Source: 2015 Journal Citation Reports, Thomson Reuters 2016)
Circulation:
The Publisher does not disclose the circulation.
Frequency:
Published 12 times a year.
Affiliations:
Lung Cancer is affiliated with the International Lung Cancer Consortium, the European Thoracic Oncology Platform and the British Thoracic Oncology Group.
Aims of the journal:
Lung Cancer is an international publication covering the clinical, translational and basic science of malignancies of the lung and chest region.
Content:
The journal includes original research articles, early reports, review articles and editorials covering the prevention, epidemiology and etiology, basic biology, pathology, clinical assessment, surgery, chemotherapy, radiotherapy, combined treatment modalities, other treatment modalities and outcomes of lung cancer are all welcome.
Letters to the journals are also welcomed although authors should be aware that the majority will be published online only. Early reports should briefly describe the initial results of a research topic and will be expedited through peer-review.
Manuscripts describing studies on cell lines will only be considered if the data compares at least two types of distinct cell lines and the results have general implications on the understanding of the biology of chest tumours. Authors of studies on cell lines must also agree to make freely available to other researchers any of the cells, clones of cells, or DNA or antibodies, etc, that were used in the research reported and that are not available from commercial suppliers.
Editorial contacts:
The full editorial board can be viewed here.
Manuscript submission:
Author guidelines can be viewed here.
Online manuscripts submissions can be made here.
Email
email@cision.one
Website
site@cision.one
Social media
Location
United Kingdom
Frequency
upgrade
Circulation
upgrade
Sectors
Oncology
Bio
Impact Factor: 3.767 (Source: 2015 Journal Citation Reports, Thomson Reuters 2016) 5-Year Impact Factor: 3.760 (Source: 2015 Journal Citation Reports, Thomson Reuters 2016) Circulation: The Publisher does not disclose the circulation. Frequency: Published 12 times a year. Affiliations: Lung Cancer is affiliated with the International Lung Cancer Consortium, the European Thoracic Oncology Platform and the British Thoracic Oncology Group. Aims of the journal: Lung Cancer is an international publication covering the clinical, translational and basic science of malignancies of the lung and chest region. Content: The journal includes original research articles, early reports, review articles and editorials covering the prevention, epidemiology and etiology, basic biology, pathology, clinical assessment, surgery, chemotherapy, radiotherapy, combined treatment modalities, other treatment modalities and outcomes of lung cancer are all welcome. Letters to the journals are also welcomed although authors should be aware that the majority will be published online only. Early reports should briefly describe the initial results of a research topic and will be expedited through peer-review. Manuscripts describing studies on cell lines will only be considered if the data compares at least two types of distinct cell lines and the results have general implications on the understanding of the biology of chest tumours. Authors of studies on cell lines must also agree to make freely available to other researchers any of the cells, clones of cells, or DNA or antibodies, etc, that were used in the research reported and that are not available from commercial suppliers. Editorial contacts: The full editorial board can be viewed here. Manuscript submission: Author guidelines can be viewed here. Online manuscripts submissions can be made here.
Website
Social media
Location
Frequency
Circulation
Sectors
Oncology
Most recent articles by Lung Cancer
Lorem ipsum dolor sit amet, consectetur adipiscing elit
Article description
Lorem ipsum dolor sit amet, consectetur adipiscing elit
Article description
Lorem ipsum dolor sit amet, consectetur adipiscing elit
Article description
Explore outlets similar to Lung Cancer
-
OncologyLiveEstablished in 2000 as Oncology Net Guide and rebranded in March 2011 as OncLive. Written for physicians to enable them to keep up to date with the rapidly expanding amount of medical information and resources on oncology. Designed as a handbook for frequent referencing and written in an easy-to-understand style. Articles are quick-reading, timely, provides practical information and information about new medical treatments. Media Alert: Tuesday April 12th 2011 Oncology Net Guide has changed its name to OncLive. Anita Shaffer is Associate Editor in charge of the oncology research and technology magazine. She may be reached at +1 (609) 716 7777 Ext 192 and ashaffer@onclive.com
ViewMMedical News TodayBackground and Format: Launched in 2003, Medical News Today is a website overseen by Healthline Media UK Ltd and is aimed at healthcare professionals and consumers. Covers health news, diseases, nutrition & diet and pain & aesthetics. For more information about advertising rates, the team can be reached here. Circulation: Source: Publisher.
View
Targeted OncologyTargeted Oncology is an online resource for oncology news and research, carrying content from Intellisphere's printed oncology journals, Targeted Therapies and The Journal of Targeted Therapies.
ViewJJAMA OncologySet to launch in February 2015, this medical journal aimed at physicians covers oncology. Will feature all aspects of medical, radiation, and surgical oncology and its subspecialties
ViewAASH Clinical NewsASH Clinical News is a news publication from the American Society of Hematology and serves as a source for worldwide news and perspectives on hematology and oncology. Coverage includes blood disorders and related topics of interest to hematologists, including developments in oncology, endocrinology and cardiology. Each month it provides the latest updates in the field along with perspectives and opinions from key leaders as well as tools and resources to help clinicians with quality and performance improvement, patient education, and the economics of running a practice.
ViewUse CisionOne to find more relevant outletsDiscover the stories that impact your brand. In realtime.
CisionOne delivers relevant news, trends and conversations that matter to your brand with the world’s most comprehensive media monitoring service across Print, Online, TV, Radio, Social, Magazines, Podcasts and more.
